Target intelligence / Profile preview

Slowmo homolog 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Slowmo homolog 2 pseudogene (ENSG00000254182) is annotated as a human pseudogene related by sequence homology to the "slowmo" gene family found in Drosophila and other organisms, but in humans it exists in a non-functional form (pseudogene)[4]. Pseudogenes typically arise from protein-coding genes that have lost their coding potential due to disabling mutations, insertions, or deletions, and therefore do not produce functional proteins[1][3]. Although some pseudogenes can be transcribed into noncoding RNAs and may participate in gene regulation as regulatory RNAs or via mechanisms involving sequence similarity (such as acting as microRNA decoys or engaging in gene conversion), there is no evidence that this particular pseudogene fulfills any functional, regulatory, or disease-related role[2][3]. Pseudogenes are generally not considered valid therapeutic targets because they lack protein-coding function and are not active receptors, enzymes, or transporters[1][3]. The label "slowmo homolog 2 pseudogene" indicates that this entry is not a druggable target and would not be used in standard pharmacological research or drug development. If you are seeking a biologically relevant protein or target, this gene is not appropriate.

Other names
slowmo homolog 2 (Drosophila) pseudogene 1
02

Biological functions

Other (No known protein-coding function; some pseudogenes can be transcribed and may play a regulatory RNA role)
03

Disease associations

Other (While some pseudogenes are implicated in disease mechanisms, there is no evidence implicating this specific pseudogene in human disease)

Beyond the preview

Go deeper on Slowmo homolog 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slowmo homolog 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call